About this episode
NOTHING DISCUSSED IN THIS PODCAST IS MEDCAL ADVICE In this weeks episode of Bioactive Riley (@cannabichem) talks with Chris Witowski the CEO and cofounder of the biotech company Psilera investigating new psychedelic substances for the treatment of conditions like anxiety, depression, and PTSD. Chris discusses the general pipeline for how Psilera goes about investigating new drug candidates as well as the advantages to non-hallucinogenic psychedelic drugs. Thanks for listening and subscribing to this channel- mad love Reach Chris and the rest of the Psilera team at: [email protected] twitter: @Psilera IG: @Psilera Papers discussed in this episode: "Psychedelics promote plasticity by directly binding to BDNF receptor TrkB" https://www.nature.com/articles/s4159...
Thank you to our podcast sponsor Boveda, and check out humidity packs for your cannabis at https://bovedainc.com/
Learn more about your ad choices. Visit megaphone.fm/adchoices
Get every episode summarized
Each time BIOACTIVE publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from BIOACTIVE
Cannabis and Driving with Dr. Denise Valenti
BIOACTIVE
Sep 4, 20261:03:15completed
The Gut-Brain Axis with Dr. Rick Pescatore
BIOACTIVE
Aug 25, 202652:53pending
What went down at the Cannabis Rescheduling Hearing with Max Jackson
BIOACTIVE
Aug 7, 20261:04:05pending
Should THC Be a Range Instead of One Number? with guest Ben Cleary
BIOACTIVE
Jul 30, 20261:03:18pending